Cagrilintide (5mg) + Semaglutide (5mg) Blend

Description

Cagrilintide (5mg) + Semaglutide (5mg) Blend

Overview

This dual-peptide weight management formulation combines Cagrilintide (an amylin analog) and Semaglutide (a GLP-1 receptor agonist) to enhance appetite suppression, fat loss, and metabolic control.

Key Benefits:

✔ Suppresses appetite and promotes satiety
✔ Enhances fat oxidation and weight loss
✔ Regulates blood sugar levels and insulin sensitivity
✔ Supports cardiovascular and metabolic health

Mechanism of Action:

• Cagrilintide: Mimics amylin, reducing hunger and food intake.
• Semaglutide: Activates GLP-1 receptors, slowing gastric emptying and improving insulin function.

Citations:

1. Lau, J. et al. “Cagrilintide and its synergistic effects with GLP-1 receptor agonists,” Nat Metab, 2021.
2. Wilding, J. et al. “Semaglutide’s role in weight management,” N Engl J Med, 2021.